Compare ACM Research Inc (ACMR) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACM Research Inc vs Regeneron Pharmaceuticals Inc — how do they compare? ACM Research Inc trades at $82.61 (market cap $5.57B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 14.7× ACM Research Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while ACM Research Inc pays none. Which is the better fit depends on your goals.
| ACMR | REGN | |
|---|---|---|
Market Cap | $5.57B | $82.06B |
Sector | Technology | Health |
52-Week High | $126.89 | $812.27 |
52-Week Low | $24.93 | $555.51 |
Enterprise Value | $4.48B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ACM Research Inc
ACM Research develops and manufactures semiconductor process equipment, specializing in wafer cleaning and electroplating solutions. Its tools are used by global chipmakers to improve productivity and yield for logic and memory chips.
Read more on ACMR →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
